CTLA4 and melanoma: Moreover, melanoma patients treated with CTLA-4 blockade showed improved survival, if their baseline microbiota were enriched with Faecalibacterium genus and other Firmicutes. On the opposite, patients whose microbiota were driven by Bacteroides showed inferior survival under CTLA-4 blockade [126].